Pulmonx (LUNG) Gross Profit (2019 - 2025)

Pulmonx (LUNG) has 7 years of Gross Profit data on file, last reported at $16.1 million in Q3 2025.

• On a quarterly basis, Gross Profit rose 6.83% year-over-year to $16.1 million in Q3 2025; TTM through Sep 2025 was $67.2 million, a 14.24% increase from a year earlier, with the FY2024 full-year figure at $62.0 million, up 22.16% from the prior year.
• Gross Profit for Q3 2025 stood at $16.1 million, down from $17.2 million in the prior quarter.
• Over the last five years, Gross Profit for LUNG reached as high as $17.6 million in Q4 2024 and fell as low as $6.6 million in Q1 2021.
• Historically, Gross Profit has averaged $12.5 million across 5 years, with a median of $12.7 million in 2023.
• Across the five-year window, Gross Profit jumped 792.19% in 2021 and climbed 4.24% in 2022, its largest moves.
• Year by year, Gross Profit stood at $10.3 million in 2021, then increased by 9.1% to $11.2 million in 2022, then gained by 28.76% to $14.4 million in 2023, then climbed by 22.15% to $17.6 million in 2024, then retreated by 8.74% to $16.1 million in 2025.
• Per Business Quant data, the three most recent Gross Profit figures were $16.1 million in Q3 2025, $17.2 million in Q2 2025, and $16.3 million in Q1 2025.